Postirradiation osteosarcoma of the mandible with heterologous differentiation.
Heterologous differentiation in osteosarcoma is rare, with only 17 cases previously described in the literature. We report a case of a mandibular osteoblastic osteosarcoma with rhabdomyosarcomatous differentiation in a 45-year-old man who had a history of Hodgkin lymphoma that was treated with chemotherapy and radiation. Radiographs showed a destructive osteoblastic tumor of the mandible that was proven by biopsy to be osteosarcoma. After the patient underwent neoadjuvant chemotherapy, the tumor was resected. It contained a high-grade osteosarcoma composed of osteoblastic and chondroblastic elements that had no definitive response to therapy. Within the center of the lesion was a discrete focus of pleomorphic cells with rhabdomyosarcomatous differentiation that was confirmed by immunohistochemical stains for desmin, myogenin, and myogenic differentiation antigen 1. The patient received additional chemotherapy and radiation therapy but developed lung, brain, and spinal metastases and died 7 months after surgery. To our knowledge, this is the first report of osteosarcoma of the mandible with heterologous differentiation.
Seethala
Raja R
RR
Department of Pathology, M. D. Anderson Cancer Center, Houston, TX 77030, USA.
Sturgis
Erich M
EM
Raymond
A Kevin
AK
Deavers
Michael T
MT
D002471:Cell Transformation, Neoplastic; D003131:Combined Modality Therapy; D017809:Fatal Outcome; D006689:Hodgkin Disease / Q000473:pathology / Q000532:radiotherapy; D006801:Humans; D008297:Male; D008339:Mandibular Neoplasms / Q000209:etiology / Q000473:pathology* / Q000628:therapy; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009381:Neoplasms, Radiation-Induced / Q000473:pathology*; D016609:Neoplasms, Second Primary / Q000473:pathology*; D012516:Osteosarcoma / Q000209:etiology / Q000556:secondary* / Q000628:therapy; D012208:Rhabdomyosarcoma / Q000209:etiology / Q000556:secondary* / Q000628:therapy